Medistep Healthcare
Medistep Healthcare (MEDISTEP) share price was ₹18.75 at the 28 Oct 2026 close; market capitalisation ₹26.64 Cr; P/E (TTM) 11.72; sector Consumer Goods. The share price fell 29.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue rose 25.9% year on year to ₹35.76 Cr and net profit rose 22.4% year on year to ₹3.01 Cr (compared with Mar 2025). Promoters held 68.96% of Medistep Healthcare in Sep 2026, unchanged from Mar 2026. Its Tapetide Score is 53/100 (Average) as of 28 Oct 2026.
Key Fundamentals
SMEPersonal ProductsFMCGPrice-based figures as of 29 Oct 2026, 10:46 IST · TTM
Peer Comparison
Fast Moving Consumer Goods › Consumer Goods › Personal Care
| ₹826.30 | 44.16 | 84,556 Cr | 6.69 | 1.21% | 14.71% | 21.44% | 16,116 Cr | 1,914 Cr | |
| ₹367.40 | 33.04 | 65,175 Cr | 5.71 | 2.31% | 15.83% | 20.96% | 14,181 Cr | 1,947 Cr | |
| ₹1,616.40 | 32.28 | 43,964 Cr | 27.18 | 1.50% | 83.66% | 107.36% | 6,491 Cr | 1,362 Cr | |
| ₹325.75 | 319.36 | 43,802 Cr | 97.24 | 1.58% | 24.01% | 30.87% | 484 Cr | 137 Cr | |
| ₹7,194.00 | 35.09 | 23,442 Cr | 24.77 | 3.28% | 69.13% | 84.58% | 3,202 Cr | 668 Cr | |
| ₹6,877.00 | 28.23 | 22,323 Cr | 29.63 | 3.77% | 113.67% | 135.44% | 4,289 Cr | 790 Cr | |
| ₹372.30 | 21.71 | 16,251 Cr | 5.56 | 2.71% | 26.53% | 28.59% | 3,997 Cr | 749 Cr | |
| Medistep Healthcare (this company) | ₹18.75 | 11.72 | 27 Cr | 0.70 | 0.00% | 15.82% | 21.78% | 21 Cr | 2 Cr |
| Median 8 companies | ₹599.30 | 32.66 | 33,622 Cr | 15.73 | 1.95% | 25.27% | 29.73% | 4,143 Cr | 770 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 95/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.77 times its book value
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 203 days.
Technical Indicators
Oscillators
Neutral
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year Operating margin 11.94% · Mar 2026
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 21.25 | 28.4 | 35.07 | 35.76 |
| Expenses | 18.96 | 25.09 | 31.09 | 31.49 |
| Operating Profit | 2.29 | 3.31 | 3.98 | 4.27 |
| OPM % | 10.78% | 11.65% | 11.35% | 11.94% |
| Other Income | 0 | 0 | 0 | 0.02 |
| Interest | 0.02 | 0.01 | 0 | 0.25 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.01 |
| PBT | 2.25 | 3.28 | 3.97 | 4.03 |
| Tax % | 25.33% | 25.3% | 25.19% | 25.06% |
| Net Profit | 1.69 | 2.46 | 2.97 | 3.01 |
| EPS (₹) | 1.61 | 2.35 | 2.09 | 2.12 |
Profit & Loss
| Particulars | Mar 2024 9m | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 31.6 | 49.65 | 70.83 |
| Expenses | 27.64 | 44.04 | 62.57 |
| Operating Profit | 3.96 | 5.61 | 8.26 |
| OPM % | 12.53% | 11.3% | 11.66% |
| Other Income | 0.01 | 0 | 0.02 |
| Interest | 0.06 | 0.04 | 0.26 |
| Depreciation | 0.02 | 0.03 | 0.03 |
| PBT | 3.89 | 5.54 | 7.99 |
| Tax % | 25.19% | 25.09% | 25.16% |
| Net Profit | 2.91 | 4.14 | 5.98 |
| EPS (₹) | 5.94 | 3.96 | 4.21 |
| Div. Payout % | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 4.9 | 10.47 | 14.21 |
| Reserves | 6.79 | 6.89 | 23.62 |
| Borrowings | 0.33 | 0.64 | 5.18 |
| Other Liabilities | 2.93 | 5 | 7.29 |
| Total Liabilities | 14.95 | 23 | 50.3 |
| Fixed Assets | 0.15 | 0.14 | 0.12 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 14.8 | 22.86 | 50.18 |
| Total Assets | 14.95 | 23 | 50.3 |
Cash Flow
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Operating | -7.11 | 0.02 | -19.48 |
| Investing | -0.15 | 0 | -0.01 |
| Financing | 7.24 | 1.28 | 18.79 |
| Net Cash Flow | -0.02 | 1.3 | -0.7 |
| Free Cash Flow | -7.26 | 0.02 | -19.49 |
| CFO/OP | -180 | 0 | -224 |
Ratios
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Debtor Days | 159 | 148 | 203 |
| Inventory Days | 12.41 | 9.23 | 36.52 |
| Days Payable | 18.81 | 20.55 | 21.57 |
| Cash Conversion Cycle | 152 | 137 | 218 |
| Working Capital Days | 134 | 117 | 191 |
| ROCE % | — | 37.18% | 27.04% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Medistep Healthcare insights
53 extracted metrics + investor summaries across FY24–FY26.
Documents
Frequently Asked Questions about Medistep Healthcare
What does Medistep Healthcare Ltd do?
Where is Medistep Healthcare Ltd (MEDISTEP) listed?
Which sector does Medistep Healthcare Ltd belong to?
What is the market capitalisation of Medistep Healthcare Ltd?
What is the PE ratio of Medistep Healthcare Ltd?
What is the 52-week high and low of Medistep Healthcare Ltd?
What is the Return on Equity (ROE) of Medistep Healthcare Ltd?
Company Information
Incorporated in June 2023, Medistep Healthcare Ltd manufactures and trades healthcare and personal care products.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MEDISTEP.md for Medistep Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.